Extraction-free SARS-CoV-2 nucleic acid detection method and kit
The invention provides an extraction-free method and a kit for qualitatively detecting SARS-CoV-2 by fluorescence polymerase chain reaction (fluorescence PCR), and belongs to the field of biotechnology and medicine. The method integrates sample nucleic acid release and amplification. The kit compris...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention provides an extraction-free method and a kit for qualitatively detecting SARS-CoV-2 by fluorescence polymerase chain reaction (fluorescence PCR), and belongs to the field of biotechnology and medicine. The method integrates sample nucleic acid release and amplification. The kit comprises a lysis solution and a rapid enzyme, can directly lyse and amplify respiratory secretions of a patient, make a whole detection process fast and simple, reduce chance of mutual contamination, obtain accurate and reliable PCR test results, can diagnose presence of SARS-CoV-2 in patient secretions as soon as possible, and has important application value in the fields of disease monitoring and clinical diagnosis.
本发明提供一种免提取荧光聚合酶链反应(荧光PCR)定性检测新型冠状病毒的方法和试剂盒,属于生物技术与医学领域。本发明的方法将样本核酸释放与扩增融为一体,试剂盒中包含了裂解液和快速酶,可以直接对病人呼吸道分泌物进行裂解与扩增,使整个检测过程快速,简便,减少相互污染的机会,获得的PCR检测结果准确可靠,能够尽快确诊病人分泌物中是否存在新型冠状病毒,在疾病监测、临床诊断等领域具有重要的应用价值。 |
---|